Literature DB >> 24152939

The end of AIDS: HIV infection as a chronic disease.

Steven G Deeks1, Sharon R Lewin, Diane V Havlir.   

Abstract

The success of antiretroviral therapy has led some people to now ask whether the end of AIDS is possible. For patients who are motivated to take therapy and who have access to lifelong treatment, AIDS-related illnesses are no longer the primary threat, but a new set of HIV-associated complications have emerged, resulting in a novel chronic disease that for many will span several decades of life. Treatment does not fully restore immune health; as a result, several inflammation-associated or immunodeficiency complications such as cardiovascular disease and cancer are increasing in importance. Cumulative toxic effects from exposure to antiretroviral drugs for decades can cause clinically-relevant metabolic disturbances and end-organ damage. Concerns are growing that the multimorbidity associated with HIV disease could affect healthy ageing and overwhelm some health-care systems, particularly those in resource-limited regions that have yet to develop a chronic care model fully. In view of the problems inherent in the treatment and care for patients with a chronic disease that might persist for several decades, a global effort to identify a cure is now underway.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24152939      PMCID: PMC4058441          DOI: 10.1016/S0140-6736(13)61809-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  93 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  Toward an AIDS-free generation.

Authors:  Anthony S Fauci; Gregory K Folkers
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

3.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

4.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

5.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

6.  Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates.

Authors:  Ivona Pandrea; Elaine Cornell; Cara Wilson; Ruy M Ribeiro; Dongzhu Ma; Jan Kristoff; Cuiling Xu; George S Haret-Richter; Anita Trichel; Cristian Apetrei; Alan Landay; Russell Tracy
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

7.  Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.

Authors:  Yves Levy; Christine Lacabaratz; Laurence Weiss; Jean-Paul Viard; Cecile Goujard; Jean-Daniel Lelièvre; François Boué; Jean-Michel Molina; Christine Rouzioux; Véronique Avettand-Fénoêl; Thérèse Croughs; Stéphanie Beq; Rodolphe Thiébaut; Geneviève Chêne; Michel Morre; Jean-François Delfraissy
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

8.  High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.

Authors:  Veronica D Gonzalez; Karolin Falconer; Kim G Blom; Olle Reichard; Birgitte Mørn; Alex Lund Laursen; Nina Weis; Annette Alaeus; Johan K Sandberg
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

9.  Simplified ART delivery models are needed for the next phase of scale up.

Authors:  Nathan Ford; Edward J Mills
Journal:  PLoS Med       Date:  2011-07-19       Impact factor: 11.069

10.  Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

Authors:  Steven A Yukl; Eli Boritz; Michael Busch; Christopher Bentsen; Tae-Wook Chun; Daniel Douek; Evelyn Eisele; Ashley Haase; Ya-Chi Ho; Gero Hütter; J Shawn Justement; Sheila Keating; Tzong-Hae Lee; Peilin Li; Danielle Murray; Sarah Palmer; Christopher Pilcher; Satish Pillai; Richard W Price; Meghan Rothenberger; Timothy Schacker; Janet Siliciano; Robert Siliciano; Elizabeth Sinclair; Matt Strain; Joseph Wong; Douglas Richman; Steven G Deeks
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more
  611 in total

1.  Enhancing the Emotional Wellbeing of Perinatally HIV Infected Youth across Global Contexts.

Authors:  Latoya Small; Micaela Mercado; Priya Gopalan; Gisselle Pardo; Claude Ann Mellins; Mary McKernan McKay
Journal:  Glob Soc Welf       Date:  2014-03

2.  Association of Markers of Inflammation with Sleep and Physical Activity Among People Living with HIV or AIDS.

Authors:  Michael D Wirth; Jason R Jaggers; Wesley D Dudgeon; James R Hébert; Shawn D Youngstedt; Steven N Blair; Gregory A Hand
Journal:  AIDS Behav       Date:  2015-06

Review 3.  HIV infection and immune activation: the role of coinfections.

Authors:  Afroditi Boulougoura; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

4.  Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.

Authors:  T C Do; D Boettiger; M Law; S Pujari; F Zhang; R Chaiwarith; S Kiertiburanakul; M P Lee; R Ditangco; W W Wong; K V Nguyen; T P Merati; T T Pham; A Kamarulzaman; S Oka; E Yunihastuti; N Kumarasamy; P Kantipong; J Y Choi; O T Ng; N Durier; K Ruxrungtham
Journal:  HIV Med       Date:  2016-08       Impact factor: 3.180

Review 5.  ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities.

Authors:  Katherine G Quinn; Dexter R Voisin
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

Review 6.  Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form.

Authors:  David H Altreuter; Ameya R Kirtane; Tyler Grant; Cecilia Kruger; Giovanni Traverso; Andrew M Bellinger
Journal:  Expert Opin Drug Deliv       Date:  2018-11-13       Impact factor: 6.648

7.  Longitudinal Changes in Spirometry in South African Adolescents Perinatally Infected With Human Immunodeficiency Virus Who Are Receiving Antiretroviral Therapy.

Authors:  Leah N Githinji; Diane M Gray; Sipho Hlengwa; Takwanisa Machemedze; Heather J Zar
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

8.  Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances.

Authors:  Caitlin N Pope; Jessica L Montoya; Elizabeth Vasquez; Josué Pérez-Santiago; Ronald Ellis; J Allen McCutchan; Dilip V Jeste; David J Moore; María J Marquine
Journal:  J Neurovirol       Date:  2020-07-30       Impact factor: 2.643

9.  Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.

Authors:  Alison G Abraham; Annie Darilay; Heather McKay; Joseph B Margolick; Michelle M Estrella; Frank J Palella; Robert Bolan; Charles R Rinaldo; Lisa P Jacobson
Journal:  J Infect Dis       Date:  2015-03-11       Impact factor: 5.226

10.  The relationship of physical performance with HIV disease and mortality.

Authors:  Meredith Greene; Kenneth Covinsky; Jacquie Astemborski; Damani A Piggott; Todd Brown; Sean Leng; Noya Galai; Shruti H Mehta; Jack Guralnik; Kushang V Patel; Gregory D Kirk
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.